VZV Antibodies

Santa Cruz Biotechnology offers a broad range of VZV Antibodies for studying Varicella-Zoster Virus (VZV), a member of the herpesvirus family responsible for chickenpox and shingles. VZV Antibodies are available for various research applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Varicella-Zoster Virus is crucial for understanding viral pathogenesis and immune response, as VZV can remain dormant in the body and reactivate later in life, leading to significant health complications. Research into VZV molecular mechanisms has revealed complex interactions between viral proteins and host cellular pathways. Understanding VZV infection patterns and transmission dynamics continues to drive scientific exploration in the field of virology. The study of VZV is essential for developing effective vaccines and therapeutic strategies to combat associated diseases. Investigating VZV proteins helps illuminate viral entry mechanisms and cellular responses during infection. Current research focuses on understanding VZV latency and reactivation patterns in neural tissues. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific knowledge of VZV and developing improved treatment strategies.